<DOC>
	<DOCNO>NCT00216242</DOCNO>
	<brief_summary>The goal study determine whether Fluviral , inactivate , injectable trivalent influenza vaccine ( flu shot ) effective prevent respiratory illness severe enough limit normal daily activity show virus culture cause influenza virus . The study also examine safety vaccine collect measurement immune system response produce vaccine .</brief_summary>
	<brief_title>Study Protective Effect Injectable Influenza Vaccine Against Influenza Illness Adults Under 50 y.o .</brief_title>
	<detailed_description>Yearly influenza ( flu ) epidemic cause large burden lose work school time among young person excess hospitalization death among elderly . Injectable flu vaccine generally believe effective , formal study use modern culture method prove limit . This study compare rate respiratory illness associate positive influenza virus culture healthy young adult ( group low risk serious influenza complication ) receive Fluviral ( injectable flu vaccine ) rate illness healthy young adult receive injection saline ( salt water ) . The rate local vaccine reaction symptom compare vaccine salt water group , immune response vaccine measure .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Good health history physical exam Reliable access telephone Study comprehension inform consent Systolic BP &gt; /= 140 ; diastolic BP &gt; /= 90 Uncontrolled medical psychiatric illness ( change last 3 month ) Cancer , treatment cancer within 3 year Cardiopulmonary disease require chronic treatment Insulin dependent diabetes mellitus Renal dysfunction ( creatinine &gt; /= 1.7 mg/dL ) Hemoglobinopathies Clotting disorder increase risk IM injection Immunosuppressive illness drug History demyelinate disease ( esp . GuillianBarre syndrome ) Employment profession high risk influenza transmission Household contact highrisk individual Receipt : ) Immunosuppressive drug ) systemic glucocorticoid &gt; /= 10 mg prednisone per day ii ) cytotoxic drug b ) Investigational drug within 30 day , plan , study c ) Blood product within 3 month , plan , study ) Influenza vaccine within 9 month study e ) Other vaccine within 30 day , plan , study History : 1 . Severe reaction influenza vaccine 2 . Allergy egg proteins 3 . Sensitivity mercurials Pregnancy/ high risk pregnancy 1 . Positive urine pregnancy test treatment 2 . Women childbearing potential without credible contraceptive plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>influenza</keyword>
	<keyword>vaccine</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>immunogenicity</keyword>
</DOC>